1315 Capital II L.P. 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-16 4:35 pm Purchase | 2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 9,405,940 68.000% | 6,239,274 (+197.03%) | Filing |
| 2021-11-12 5:21 pm Unchanged | 2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 3,166,666 26.400% | 0 (Unchanged) | Filing |
| 2021-05-19 5:39 pm Unchanged | 2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 3,166,666 26.500% | 0 (Unchanged) | Filing |
| 2021-01-21 4:49 pm Unchanged | 2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 3,166,666 26.600% | 0 (Unchanged) | Filing |
| 2020-04-30 08:15 am Unchanged | 2020-04-02 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 3,166,666 26.700% | 0 (Unchanged) | Filing |
| 2020-01-23 5:41 pm Purchase | 2020-01-15 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 3,166,666 26.800% | 3,166,666 (New Position) | Filing |